https://www.selleckchem.com/products/vx-11e.html
9 years. Before use of topical ocular moxifloxacin the conjunctival and nasal culture positivity rates in the treatment group were both 100%, versus 90% and 95%, respectively, in the control group. At the follow-up exam the conjunctival and nasal mucosa culture positivity rates in the treatment group decreased to 20% (4/2 and 30% (6/2, respectively (P less then 0.001), versus 85% (17/2 and 80% (16/2, respectively, in the control group (P = 0.68 and P = 0.72 for conjunctival and nasal). This is the first study to show that moxif
Like
Comment
Share
